Needham Reiterates Buy on DocGo, Maintains $14 Price Target
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a price target of $14.
August 23, 2023 | 9:52 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo and maintained a price target of $14. This could potentially boost investor confidence in the stock.
Analyst ratings often influence investor sentiment. A reiterated 'Buy' rating indicates that the analyst continues to have confidence in the company's prospects. This, coupled with a maintained price target, could potentially lead to increased investor interest and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100